Mersana Therapeutics, Inc.MRSNNASDAQ
LOADING
|||
Analyst Sentiment
Analysts lean bullish — 58% recommend buying.
Consensus Rating
Buy
19 analysts·Moderate coverage
58%
Rating Distribution
Strong Buy
00%
Buy
1158%
Hold
842%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Current price is 42% above analyst consensus — significant downside expected.
Bear Case
$17.00
-42%
Consensus
$17.00
-42%
Bull Case
$17.00
+-42%
Price Range19 analysts
Low
Consensus
High
$17.00
$17.00
Current Target
Current Price
$29.08
Above Target
$12.08
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.